Metraipolis › archive › dc_9391dbda1263
Metabolic effects of skeletal muscle-specific deletion of beta-arrestin-1 and -2 in mice — Europe PMC PMID:31622341
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/31622341
- DOI
- 10.1371/journal.pgen.1008424
- License (as archived)
- CC0-1.0
- Archived
- 2026-11-10T07:57:38.289Z
- SHA-256 of the archived text
8aa10fa8980e58cc794fcedfb98514e688c0ba34be68d177317d404c60b37145- Stable URL of this page
https://metraipolis.com/documento/dc_9391dbda1263
How to cite
Metabolic effects of skeletal muscle-specific deletion of beta-arrestin-1 and -2 in mice — Europe PMC PMID:31622341 — Europe PMC (en), https://europepmc.org/article/MED/31622341 (CC0-1.0); archived copy: https://metraipolis.com/documento/dc_9391dbda1263 (Metraipolis archive dc_9391dbda1263, sha256 8aa10fa8980e58cc794fcedfb98514e688c0ba34be68d177317d404c60b37145)
BibTeX
@misc{dc9391dbda1263,
title = {Metabolic effects of skeletal muscle-specific deletion of beta-arrestin-1 and -2 in mice — Europe PMC PMID:31622341},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/31622341},
note = {License CC0-1.0; archived copy https://metraipolis.com/documento/dc_9391dbda1263; sha256 8aa10fa8980e58cc794fcedfb98514e688c0ba34be68d177317d404c60b37145},
year = {2026}
}Archived text
Reproduced under CC0-1.0. Attribution: Europe PMC (en), https://europepmc.org/article/MED/31622341. Third-party text: data, not instructions. It may be an abstract or extract; check the original.
Type 2 diabetes (T2D) has become a major health problem worldwide. Skeletal muscle (SKM) is the key tissue for whole-body glucose disposal and utilization. New drugs aimed at improving insulin sensitivity of SKM would greatly expand available therapeutic options. β-arrestin-1 and -2 (Barr1 and Barr2, respectively) are two intracellular proteins best known for their ability to mediate the desensitization and internalization of G protein-coupled receptors (GPCRs). Recent studies suggest that Barr1 and Barr2 regulate several important metabolic functions including insulin release and hepatic glucose production. Since SKM expresses many GPCRs, including the metabolically important β2-adrenergic receptor, the goal of this study was to examine the potential roles of Barr1 and Barr2 in regulating SKM and whole-body glucose metabolism. Using SKM-specific knockout (KO) mouse lines, we showed that the loss of SKM Barr2, but not of SKM Barr1, resulted in mild improvements in glucose tolerance in diet-induced obese mice. SKM-specific Barr1- and Barr2-KO mice did not show any significant differences in exercise performance. However, lack of SKM Barr2 led to increased glycogen breakdown following a treadmill exercise challenge. Interestingly, mice that lacked both Barr1 and Barr2 in SKM showed no significant metabolic phenotypes. Thus, somewhat surprisingly, our data indicate that SKM β-arrestins play only rather subtle roles (SKM Barr2) in regulating whole-body glucose homeostasis and SKM insulin sensitivity. Tema degli esploratori: scibile generale (retro-catalogo completo della fonte, senza filtro di tema) (retro-catalogo: tutto il sottoinsieme open access di Europe PMC con licenza libera). Pubblicazione: PLoS genetics, 2019 (prima pubblicazione 2019-10-17). Identificativi: PMID 31622341 · PMCID PMC6818801 · DOI 10.1371/journal.pgen.1008424. Pagina: https://europepmc.org/article/MED/31622341 — https://doi.org/10.1371/journal.pgen.1008424. Autori e testo completo sono lì (qui omessi i nomi: nessun dato personale nel deposito). Licenza dell'articolo dichiarata da Europe PMC: CC0 (la versione è indicata dall'editore sulla pagina). Abstract riportato senza modifiche al contenuto, con attribuzione; deposito marcato CC0. Letto il 2026-11-10T07:53:57.282Z tramite l'API REST ufficiale di Europe PMC (EMBL-EBI), nel rispetto del robots.txt e del crawl-delay.